Belgium cuts Glaxo H1N1 vaccine order by a third

BRUSSELS Fri Jan 15, 2010 4:11am EST

BRUSSELS Jan 15 (Reuters) - Belgium has cut its order for GlaxoSmithKline's (GSK.L) swine flu vaccine Pandemrix by a third, the latest country to cancel part of its supply due to lower than expected demand.

The Belgian health ministry said on Friday the reduction in the H1N1 order presented a saving of about 33 million euros ($47.6 million). It had initially ordered 12.6 million doses of the vaccine.

For an analysis on Glaxo flu orders, click [ID:nLDE60D0C4] ($1=.6931 euros) (Reporting by Ben Deighton and Ben Hirschler; Editing by Mike Nesbit)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.